Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M UNGER

Showing results (491-500 of 604) with videos related to

Pageof 61
Sort By:
Pilot and Feasibility Studies|June 16, 2023
Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunityIsabel H Gonzalez-Bocco, Katherine Beluch, Alyssa Cho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group studyK A Margolin, P Y Liu, L E Flaherty, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 8, 2011
Patients with idiopathic rapid-eye-movement sleep behavior disorder show normal gastric motility assessed by the 13C-octanoate breath testMarcus M Unger, Jens C Möller, Katharina Mankel, et al.
JAMA Oncology|November 7, 2024
Long-Term Adverse Effects and Complications After Prostate Cancer TreatmentJoseph M Unger, Cathee Till, Catherine M Tangen, et al.
Blood Cancer Discovery|June 28, 2021
Recommendations on eliminating racial disparities in multiple myeloma therapies: a step toward achieving equity in healthcareNicole Gormley, Lola Fashoyin-Aje, Trevan Locke, et al.
Sleep|June 17, 2010
Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regionsMarcus M Unger, Marcus Belke, Katja Menzler, et al.
JCO Oncology Advances|June 23, 2025
Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Treatment Trials: A Meta-Analysis of Industry and National Cancer Institute StudiesJoseph M Unger, Hillary S Andrews, Laura A Levit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2022
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical TrialsJoseph M Unger, Riha Vaidya, Kathy S Albain, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2025
Emerging Strategies for Drug-Based Cancer Risk ReductionMaria Daca-Álvarez, Angelo Brunori, Alessio Carbone, et al.
Cancer Immunology Research|July 5, 2014
Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survivalWilliam E Carson, Joseph M Unger, Jeffrey A Sosman, et al.
Pageof 61

Showing results (491-500 of 604) with videos related to

Sort By:
Pageof 61
Pilot and Feasibility Studies|June 16, 2023
Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunityIsabel H Gonzalez-Bocco, Katherine Beluch, Alyssa Cho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group studyK A Margolin, P Y Liu, L E Flaherty, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 8, 2011
Patients with idiopathic rapid-eye-movement sleep behavior disorder show normal gastric motility assessed by the 13C-octanoate breath testMarcus M Unger, Jens C Möller, Katharina Mankel, et al.
JAMA Oncology|November 7, 2024
Long-Term Adverse Effects and Complications After Prostate Cancer TreatmentJoseph M Unger, Cathee Till, Catherine M Tangen, et al.
Blood Cancer Discovery|June 28, 2021
Recommendations on eliminating racial disparities in multiple myeloma therapies: a step toward achieving equity in healthcareNicole Gormley, Lola Fashoyin-Aje, Trevan Locke, et al.
Sleep|June 17, 2010
Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regionsMarcus M Unger, Marcus Belke, Katja Menzler, et al.
JCO Oncology Advances|June 23, 2025
Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Treatment Trials: A Meta-Analysis of Industry and National Cancer Institute StudiesJoseph M Unger, Hillary S Andrews, Laura A Levit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2022
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical TrialsJoseph M Unger, Riha Vaidya, Kathy S Albain, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2025
Emerging Strategies for Drug-Based Cancer Risk ReductionMaria Daca-Álvarez, Angelo Brunori, Alessio Carbone, et al.
Cancer Immunology Research|July 5, 2014
Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survivalWilliam E Carson, Joseph M Unger, Jeffrey A Sosman, et al.
Pageof 61